MT-ATP6 and carcinoma: Indeed, some carcinomas present MT-ATP6 mutations [34,35] while others downregulate the expression of the catalytic subunit β-F1-ATPase [36,37] reducing in that way OXPHOS activity to favor the metabolic switch to a Warburg phenotype that promotes growth and cell survival [68].